Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy

por Lorusso, Domenica, Tripodi, Elisa, Maltese, Giuseppa, Lepori, Stefano, Sabatucci, Ilaria, Bogani, Giorgio, Raspagliesi, Francesco
Publicado 2018

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses

por Bogani, Giorgio, Tagliabue, Elena, Signorelli, Mauro, Ditto, Antonino, Martinelli, Fabio, Chiappa, Valentina, Mosca, Lavinia, Sabatucci, Ilaria, Leone Roberti Maggiore, Umberto, Lorusso, Domenica, Raspagliesi, Francesco
Publicado 2018

Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile

por Lorusso, Domenica, Maltese, Giuseppa, Sabatucci, Ilaria, Cresta, Sara, Matteo, Cristina, Ceruti, Tommaso, D’Incalci, Maurizio, Zucchetti, Massimo, Raspagliesi, Francesco, Sonetto, Cristina, Sinno, Valentina, Ronzulli, Dominique, Giolitto, Serena, de Braud, Filippo
Publicado 2020